These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8248098)

  • 41. Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3).
    Biris N; Abatzis M; Mitsios JV; Sakarellos-Daitsiotis M; Sakarellos C; Tsoukatos D; Tselepis AD; Michalis L; Sideris D; Konidou G; Soteriadou K; Tsikaris V
    Eur J Biochem; 2003 Sep; 270(18):3760-7. PubMed ID: 12950259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The integrin alpha IIb-beta 3, platelet glycoprotein IIb-IIIa, can form a functionally active heterodimer complex without the cysteine-rich repeats of the beta 3 subunit.
    Wippler J; Kouns WC; Schlaeger EJ; Kuhn H; Hadvary P; Steiner B
    J Biol Chem; 1994 Mar; 269(12):8754-61. PubMed ID: 8132607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Further studies on the topography of the N-terminal region of human platelet glycoprotein IIIa. Localization of monoclonal antibody epitopes and the putative fibrinogen-binding sites.
    Calvete JJ; Arias J; Alvarez MV; Lopez MM; Henschen A; González-Rodríguez J
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):457-63. PubMed ID: 1706596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions.
    Kauf AC; Hough SM; Bowditch RD
    Biochemistry; 2001 Aug; 40(31):9159-66. PubMed ID: 11478883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
    Piétu G; Ribba AS; Chérel G; Meyer D
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A tripeptide mimetic of von Willebrand factor residues 981-983 enhances platelet adhesion to fibrinogen by signaling through integrin alpha(IIb)beta3.
    Litjens PE; Van Willigen G; Weeterings C; Ijsseldijk MJ; Van Lier M; Koivunen E; Gahmberg CG; Akkerman JW
    J Thromb Haemost; 2005 Jun; 3(6):1274-83. PubMed ID: 15946218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cluster of basic amino acid residues in the gamma370-381 sequence of fibrinogen comprises a binding site for platelet integrin alpha(IIb)beta3 (glycoprotein IIb/IIIa).
    Podolnikova NP; Gorkun OV; Loreth RM; Yee VC; Lord ST; Ugarova TP
    Biochemistry; 2005 Dec; 44(51):16920-30. PubMed ID: 16363805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the binding of 3H-SR121566, an inhibitor of Gp IIb-IIIa activation.
    Savi P; Zamboni G; Rescanières O; Herbert JM
    Thromb Haemost; 2001 Apr; 85(4):702-9. PubMed ID: 11341508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains.
    Yokoyama K; Zhang XP; Medved L; Takada Y
    Biochemistry; 1999 May; 38(18):5872-7. PubMed ID: 10231539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential structural requirements for fibrinogen binding to platelets and to endothelial cells.
    Tranqui L; Andrieux A; Hudry-Clergeon G; Ryckewaert JJ; Soyez S; Chapel A; Ginsberg MH; Plow EF; Marguerie G
    J Cell Biol; 1989 Jun; 108(6):2519-27. PubMed ID: 2738096
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain.
    Suehiro K; Mizuguchi J; Nishiyama K; Iwanaga S; Farrell DH; Ohtaki S
    J Biochem; 2000 Oct; 128(4):705-10. PubMed ID: 11011154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Site-directed mutagenesis of the gene of Echistatin Leu14-Lys15-Glu16].
    Li H; Li X; Hu M
    Yi Chuan Xue Bao; 1996; 23(2):163-8. PubMed ID: 8695184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.
    Chen YP; Djaffar I; Pidard D; Steiner B; Cieutat AM; Caen JP; Rosa JP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10169-73. PubMed ID: 1438206
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.
    Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):785-91. PubMed ID: 7519850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of conformational specificity at GPIIb/IIIa: evaluation of conformationally constrained RGD peptides.
    Peishoff CE; Ali FE; Bean JW; Calvo R; D'Ambrosio CA; Eggleston DS; Hwang SM; Kline TP; Koster PF; Nichols A
    J Med Chem; 1992 Oct; 35(21):3962-9. PubMed ID: 1433203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on alpha v beta 3/ligand interactions using a [3H]SK&F-107260 binding assay.
    Wong A; Hwang SM; McDevitt P; McNulty D; Stadel JM; Johanson K
    Mol Pharmacol; 1996 Sep; 50(3):529-37. PubMed ID: 8794891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
    Andronati SA; Karaseva TL; Krysko AA
    Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
    Chang MC; Wang BR; Huang TF
    Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins.
    McLane MA; Vijay-Kumar S; Marcinkiewicz C; Calvete JJ; Niewiarowski S
    FEBS Lett; 1996 Aug; 391(1-2):139-43. PubMed ID: 8706902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.